Insider · CIK 0001793796

Hollander David

Reports to the SEC for 4 companies · NEW HAVEN, CT

sec.gov

Transactions

Companies

Filings

CIK

0001793796

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-01	MANEVeradermics, Inc · Stock Option (Right to Buy)A Award	Chief R&D Officer	AAward	+19.3K sh	—	—	19,300
2026-09-01	MANEVeradermics, IncA Award	Chief R&D Officer	AAward	+9,650 sh	—	—	9,650
2026-06-10	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2025-04-01	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2025-02-06	Revance Therapeutics, Inc.D Disposition to Issuer	CMO & Global Therapeutics Lead	DDisposition to Issuer	−95.2K sh	—	—	0
2025-02-04	Revance Therapeutics, Inc.U Disposition from Tender	CMO & Global Therapeutics Lead	UDisposition from Tender	−9,733 sh	$3.65	−$35.5K	95,212
2024-11-18	Revance Therapeutics, Inc.S Sale	CMO & Global Therapeutics Lead	SSale	−3,908 sh	$4.17	−$16.3K	104,945
2024-07-01	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Director	AAward	+1,778 sh	—	—	1,778
2023-09-29	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Director	AAward	0 sh	—	—	5,000
2023-03-03	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2022-02-04	AERIE PHARMACEUTICALS INCF Tax Payment	Chief R&D Officer	FTax Payment	−927 sh	$7.05	−$6,535.35	30,749
2022-02-01	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Director	AAward	+4,000 sh	—	—	4,000
2022-02-01	KPRXKIORA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2021-11-11	AERIE PHARMACEUTICALS INCF Tax Payment	Chief R&D Officer	FTax Payment	−2,162 sh	$12.06	−$26.1K	31,676
2021-02-04	AERIE PHARMACEUTICALS INCStock option (right to buy)A Award	Chief R&D Officer	AAward	+50K sh	—	—	50,000
2021-02-04	AERIE PHARMACEUTICALS INCA Award	Chief R&D Officer	AAward	+11K sh	—	—	33,838
2020-11-11	AERIE PHARMACEUTICALS INCF Tax Payment	Chief R&D Officer	FTax Payment	−2,162 sh	$13.05	−$28.2K	22,838
2019-11-11	AERIE PHARMACEUTICALS INCA Award	Chief R&D Officer	AAward	+25K sh	—	—	25,000
2019-11-11	AERIE PHARMACEUTICALS INCStock Option (right to buy)A Award	Chief R&D Officer	AAward	+110K sh	—	—	110,000

Recent filings

Accepted (ET)
Sep 34
Hollander David0001628280-26-060491
SEC(opens sec.gov)
Jun 124
Hollander David0001793796-26-000002
SEC(opens sec.gov)
Apr 24
Hollander David0001372514-25-000028
SEC(opens sec.gov)
Feb 64
Hollander David0000950170-25-015359
SEC(opens sec.gov)
Nov 194
Hollander David0001479290-24-000130
SEC(opens sec.gov)
Jul 34
Hollander David0001372514-24-000089
SEC(opens sec.gov)
Oct 34
Hollander David0001372514-23-000144
SEC(opens sec.gov)
Mar 74
Hollander David0001372514-23-000030
SEC(opens sec.gov)
Feb 84
Hollander David0001209191-22-007902
SEC(opens sec.gov)
Feb 34
Hollander David0001104659-22-011492
SEC(opens sec.gov)
Nov 154
Hollander David0001209191-21-064473
SEC(opens sec.gov)
Feb 84
Hollander David0001209191-21-008586
SEC(opens sec.gov)
Nov 124
Hollander David0001209191-20-058030
SEC(opens sec.gov)
Nov 134
Hollander David0001209191-19-056323
SEC(opens sec.gov)

Companies

Address

470 JAMES ST.

NEW HAVEN, CT, 06513